Morgan Stanley Prices €5 Billion Senior Unsecured Euro Notes Across Three Tranches
MS sits 92% above its 52-week low of $94.33.
Summary
Morgan Stanley announced the pricing of €5 billion in senior registered notes across three tranches, strengthening its funding and liquidity profile.
Key Events · Financing and Capital Events · MS
-
Debt Offering Announced
Morgan Stanley priced €5 billion (approximately $5.4 billion) of senior registered notes in three tranches.
-
Tranche Details
The offering includes €1.25 billion of floating rate notes due 2029, €2 billion of fixed/floating rate notes due 2032, and €1.75 billion of fixed/floating rate notes due 2037.
-
Funding Strategy
The issuance is part of the company's ongoing capital management, providing substantial funding for general corporate purposes and enhancing liquidity.
-
Market Acceptance
All tranches were priced at 100% of their principal amount, reflecting solid market demand for Morgan Stanley's debt.
Analysis · MS · Finance
This debt offering represents a significant capital raise for Morgan Stanley, totaling approximately $5.4 billion. As a major financial institution, such issuances are part of routine capital management to support ongoing operations, manage liquidity, and potentially refinance existing debt. The successful pricing at par across all tranches indicates strong market confidence in Morgan Stanley's creditworthiness. This move enhances the company's funding flexibility and long-term financial stability.
How filings like this one have moved
In the 30 days to Oct 1, 2026, 30.2% of the 1644 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.49%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, MS was trading at $181.57 on NYSE in the Finance sector, with a market capitalization of approximately $289.2B. The 52-week trading range was $94.33 to $192.68. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.